Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

March 05, 2008 09:01 ET

Meridian Co., Ltd. to Introduce New Lapex 2000 LipoLaser to Canadian Media and Marketplace in Eastern Canada

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 5, 2008) - Meridian Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that it's North American Exclusive Distributor, Meridian Medical Inc., (MMI) will be launching the Lapex 2000 LipoLaser to Eastern Canada this weekend at the International Anti-Aging Show (IAAS) to be held March 7-8-9 at Toronto's International Centre.

The (IAAS) features over 100 exhibitors and sponsors highlighting the latest in the world of anti-aging. The IAAS is the only show of its kind in Canada, 100% dedicated to the anti-aging industry. Meridian will be at Booth 410 featuring the Lapex 2000 LipoLaser, the Digital Pulse Analyzer and the BP Tru.

The Lapex 2000 LipoLaser continues to receive positive media attention in Eastern Canada. Meridian will be featured on Breakfast Television where they will perform a live LipoLaser treatment from their tradeshow booth on Friday, March 7th. Breakfast Television is a Canadian morning news and entertainment program which airs on CityTV Toronto each morning from 6:00am-9:00am EST.

In addition, the CH Live Morning Show will be taping a live LipoLaser treatment on their Thursday morning show which airs from 6:00am-9:00am EST. The CH Live Morning Show broadcasts throughout most of Ontario. Some cable systems outside of Ontario also carry CH including Buffalo, Philadelphia, and Western New York.

The Meridian Team welcomes your questions about the LAPEX 2000 LipoLaser. For more information about the product, please visit or contact us at to arrange for a web-based presentation.

Meridian Co., Ltd.

Meridian Co., Ltd., an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. Meridian presently holds a total of 5 worldwide patents on its technology and has received FDA approval and Health Canada approval as well as other international regulatory approvals for many of its products. Meridian has more than 2000 clients including physicians, hospitals, clinics, healthcare professionals and wellness centers in Korea, U.S., Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors, Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information